Notatki do odcinka
Nearly a year and a half ago, we released the Season 2 episode “In Sickness and in Health,” which explored new anti-amyloid therapies for Alzheimer’s disease, lecanemab and donanemab, known commercially as Leqembi and Kisunla.
After more than three years of lecanemab and nearly two years of donanemab in clinical use, how do patients, caregivers, and clinicians view these treatments today?
In this episode of The Age of Aging, we revisit the therapies reshaping Alzheimer’s care and hear from those experiencing them firsthand.
Inside this episode
Patients receiving anti amyloid therapy share…
Strona: age-of-aging.castos.com

